Prometrium Compassionate Use and Expanded Access

What "Compassionate Use" and "Expanded Access" Actually Mean for an FDA-Approved Drug

Compassionate use is a colloquial term for the FDA's expanded-access pathway. Under 21 CFR Part 312 Subpart I, expanded access allows patients to use an investigational drug outside a clinical trial when no comparable alternative exists and the potential benefit justifies the risk. [1] The FDA's own guidance is direct on this point: expanded access "is not available for drugs that have already been approved for the condition being treated." [2]

Prometrium received full FDA approval in 1998 for the prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, and for the treatment of secondary amenorrhea. [3] Because the drug is approved and commercially available, a patient cannot submit an individual expanded-access IND for it.

When Might an Expanded-Access Request Still Arise?

There is a narrow scenario. A clinician might seek expanded access if they want to use micronized progesterone for a specific unapproved indication, such as a novel neuroprotective application in traumatic brain injury, where the drug is still investigational for that use. The ProTECT III trial (N=882), published in the New England Journal of Medicine in 2014, tested intravenous progesterone for TBI and found no significant outcome benefit, which effectively closed that investigational avenue. [4] For standard hormonal and gynecologic applications, expanded access simply does not apply.

What This Means in Practice

If your prescriber told you to look into "compassionate use" for Prometrium to address cost or access, they likely meant one of the patient-assistance or affordability programs discussed below. That terminology mismatch is common and does not reflect any gap in standard-of-care coverage.

The Clinical Evidence Base for Prometrium: Why Access Matters

Understanding why clinicians fight for access to micronized progesterone specifically, rather than a synthetic progestin, requires a brief look at the trial data.

PEPI Trial and Endometrial Protection

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial (N=875) found that micronized progesterone 200 mg per day for 12 days per cycle produced significantly lower rates of endometrial hyperplasia than no progestin, while also showing a more favorable lipid profile than medroxyprogesterone acetate. [5] That distinction has driven decades of prescriber preference for the bioidentical molecule over synthetic alternatives.

WHI and the Progestin Distinction

The Women's Health Initiative, which enrolled 16,608 postmenopausal women, found an elevated breast cancer hazard ratio of 1.26 with conjugated equine estrogen plus medroxyprogesterone acetate (MPA) after 5.6 years. [6] Several observational studies, including the E3N cohort (N=80,377), found that the combination of estradiol plus micronized progesterone carried a lower breast cancer risk than estradiol plus synthetic progestins, with a relative risk of 1.00 for estradiol plus micronized progesterone versus 1.69 for estradiol plus other progestins. [7] These data inform why many clinicians prefer Prometrium and why affordability of the specific molecule matters clinically.

Endocrine Society Position

The Endocrine Society's 2022 menopause guidelines state: "Micronized progesterone is preferred over synthetic progestins when a progestogen is indicated in perimenopausal and postmenopausal women because of its more favorable safety and tolerability profile." [8] That guideline endorsement is part of why demand for the drug has grown even as generic versions have become available.

Generic Micronized Progesterone: The Most Direct Access Solution

The single most effective cost-reduction tool is generic micronized progesterone. Several manufacturers, including Actavis (now Allergan/AbbVie), Teva, and Perrigo, produce FDA-approved generic 100 mg and 200 mg capsules. [9] The FDA considers these therapeutically equivalent to Prometrium under the Orange Book rating system, carrying a "AB" therapeutic equivalence code.

Typical Cash Prices in 2025 to 2026

With a GoodRx or similar discount card, 30 capsules of generic micronized progesterone 200 mg frequently retail for $18 to $40 at major pharmacy chains. Brand-name Prometrium for the same quantity may run $180 to $250 without insurance. The price differential alone resolves the access problem for most patients who are uninsured or underinsured.

Compounded Progesterone: A Separate Regulatory Category

Some patients are directed toward compounding pharmacies. Compounded micronized progesterone is not the same regulatory product. The FDA does not review compounded formulations for safety, efficacy, or sterility in the same way it reviews approved generics. [10] The FDA's 2022 guidance on compounding from bulk drug substances reinforces that compounded versions of commercially available drugs face additional scrutiny under Section 503A of the Federal Food, Drug, and Cosmetic Act. [10] Unless a patient has a documented allergy to excipients in the FDA-approved capsule (notably peanut oil, which is a real clinical concern), FDA-approved generic micronized progesterone is the safer and more cost-effective choice.

The HealthRX Prometrium Access Decision Framework:

1. Does the patient have insurance? Check formulary tier first. Most plans cover generic micronized progesterone at Tier 1 or 2.
2. Is the drug listed as non-covered or does a prior authorization create a delay? Proceed to step 3.
3. Can a generic be substituted? If yes, apply discount card at the pharmacy counter.
4. If brand is medically necessary (e.g., documented excipient sensitivity to a generic), pursue manufacturer patient-assistance or co-pay card.
5. If the patient is uninsured and below 250% of the federal poverty level, evaluate AbbVie myAbbVie Assist eligibility.
6. If cost remains prohibitive after all the above, consult with the prescriber about whether compounding from a 503B outsourcing facility is appropriate given the patient's specific clinical profile.

Patient Assistance Programs and Manufacturer Support

AbbVie myAbbVie Assist

AbbVie operates the myAbbVie Assist patient-assistance program (myabbvieassist.com), which may provide Prometrium at no cost or reduced cost to eligible patients. Typical eligibility criteria include:

• U.S. Resident with a valid prescription
• Uninsured or underinsured
• Household income at or below a program threshold (historically 400% of the federal poverty level, though thresholds change annually)
• Not eligible for Medicaid or a comparable program

Patients apply through their prescribing clinician in most cases. Processing typically takes two to six weeks. These programs change frequently, so patients should verify current terms directly with AbbVie.

NeedyMeds and RxAssist Databases

Two independent nonprofit databases, NeedyMeds (needymeds.org) and RxAssist (rxassist.org), aggregate patient-assistance program data across manufacturers. Both are free to use and are updated more frequently than most individual manufacturer pages.

State Pharmaceutical Assistance Programs (SPAPs)

Roughly 30 U.S. States operate pharmaceutical assistance programs for residents who fall below income thresholds or who have specific diagnoses. Eligibility and drug coverage vary widely by state. The Medicare Rights Center publishes an annually updated SPAP directory at medicarerights.org.

How to Get Prometrium Cheaper: A Practical Breakdown

Insurance and Formulary Strategies

Step one is always a formulary check. Most commercial insurance plans and Medicare Part D plans cover generic micronized progesterone. If the prescriber writes "Prometrium" by brand, the pharmacy may automatically substitute the generic under most state substitution laws unless the prescriber writes "dispense as written."

If a prior authorization (PA) is required, the clinical evidence from the PEPI trial [5] and the E3N cohort [7] supports medical necessity documentation. A prescriber can typically use the WHI and E3N data to argue for micronized progesterone over a synthetic progestin on safety grounds.

Discount Cards and Coupon Programs

GoodRx, RxSaver, SingleCare, and Blink Health all negotiate discount rates with pharmacy benefit managers. These cards are free and can be used by insured and uninsured patients alike. For uninsured patients, the discount card price frequently beats the co-pay on high-deductible health plans.

One practical point: discount cards cannot be combined with Medicare or Medicaid benefits under federal law. Medicare beneficiaries should compare their Part D plan's cost-sharing against the discount card price and use whichever is lower, but they must choose one method per prescription fill.

Mail-Order Pharmacy

Mail-order fulfillment through a 90-day supply often reduces per-unit cost by 15% to 30% compared with retail 30-day fills. Most major Part D plans and commercial insurance plans offer mail-order options.

HSA and FSA Eligibility for Prometrium

Prometrium is a prescription drug approved by the FDA. Prescription drugs qualify as eligible medical expenses under Section 213(d) of the Internal Revenue Code. [11] That means:

• Health Savings Account (HSA) funds may be used to pay for Prometrium or its generic at any licensed pharmacy.
• Flexible Spending Account (FSA) funds carry the same eligibility.
• Limited-purpose FSAs (LP-FSA), which are restricted to dental and vision, do NOT cover Prometrium.

The IRS does not publish a drug-by-drug eligibility list for HSA/FSA purposes. Eligibility flows from the prescription-drug status of the product. Over-the-counter progesterone products (topical creams sold without a prescription) are not HSA/FSA-eligible unless accompanied by a prescription.

Practical Steps for HSA/FSA Reimbursement

1. Pay for the prescription at the pharmacy.
2. Keep the receipt, which should show the Rx number, drug name, date, and amount paid.
3. Submit the receipt to your HSA or FSA administrator if the payment was not made directly from the account card.
4. Some administrators require a Letter of Medical Necessity for certain expenses, but standard FDA-approved prescription drugs generally do not require this.

The IRS Publication 502 covers eligible medical expenses, including prescription drugs, in detail. [11]

Medicaid Coverage and Low-Income Pathways

Federal Medicaid law requires states to cover FDA-approved prescription drugs if the manufacturer signs a Medicaid Drug Rebate Agreement with CMS. AbbVie participates in this agreement, meaning Prometrium and its generics are available on state Medicaid formularies. [12] Generic micronized progesterone is typically placed at the lowest cost-sharing tier.

For patients who do not qualify for Medicaid but are below 200% of the federal poverty level, the 340B Drug Pricing Program offers another route. Federally qualified health centers (FQHCs), Ryan White HIV/AIDS Program grantees, and certain safety-net hospitals can purchase drugs at the 340B ceiling price and pass those savings directly to patients. The Health Resources and Services Administration (HRSA) maintains a searchable database of 340B-covered entities at hrsa.gov/opa. [13]

Medicare Part D Coverage

Medicare Part D plans are required to include at least two drugs in each therapeutic category, per CMS formulary guidelines. Generic micronized progesterone falls under the progestogen category. Most Part D formularies cover it at Tier 1 or Tier 2 cost-sharing.

Patients in the Medicare Extra Help (Low Income Subsidy) program pay reduced or zero cost-sharing for covered generics. In 2025, standard Extra Help cost-sharing for generics was capped at $4.50 per fill. The Social Security Administration administers Extra Help enrollment at ssa.gov.

The Medicare Prescription Payment Plan, introduced under the Inflation Reduction Act and active beginning January 2025, allows beneficiaries to spread out-of-pocket prescription costs over the calendar year rather than paying full amounts at the pharmacy counter. [14]

Telehealth Prescribing and Prometrium Access

HealthRX and other telehealth platforms can prescribe Prometrium or generic micronized progesterone in states where the prescribing clinician holds licensure. The Ryan Haight Online Pharmacy Consumer Protection Act requires a valid patient-provider relationship for controlled substances; progesterone is not a controlled substance under the DEA schedule and does not carry the same prescribing restrictions. [15]

Telehealth prescriptions for Prometrium can be sent to any licensed retail or mail-order pharmacy, including those that accept discount cards. The convenience benefit is real: a patient can obtain the initial consultation, prescription, and 90-day supply mail-order fill without an in-person office visit, which may reduce total cost of care when factoring in travel time and co-pays for specialist visits.

When Might a True Expanded-Access Request Be Filed?

For completeness, if a clinician genuinely needs micronized progesterone for an unapproved indication, the FDA's expanded-access process works as follows:

1. The prescribing physician submits an emergency IND or a non-emergency single-patient IND to the FDA.
2. For emergency requests, the FDA may provide verbal authorization within hours. Non-emergency individual requests are reviewed within 30 days under 21 CFR 312.310. [1]
3. The drug manufacturer must agree to provide the drug. AbbVie would need to authorize supply outside normal commercial channels.
4. Institutional Review Board (IRB) review is required for non-emergency cases.
5. The treating physician assumes full informed-consent responsibility.

This pathway is genuinely rare for Prometrium and would arise almost exclusively in a research or hospital setting exploring novel indications, not for standard HRT access.

Summary of Access Options by Patient Situation

| Patient Situation | Best First Step | |---|---| | Insured, generic allowed | Ask pharmacist to fill generic; verify Tier 1 co-pay | | Insured, brand-only PA required | Prescriber submits PA with PEPI/E3N evidence | | Uninsured, income below 400% FPL | Apply for myAbbVie Assist | | Uninsured, any income | Use GoodRx or SingleCare for generic | | Medicare Part D | Compare Tier cost-share vs. Discount card; use Extra Help if eligible | | Medicaid | Covered; confirm formulary with state plan | | HSA/FSA available | Pay at pharmacy using account card | | Safety-net clinic patient | Ask about 340B pricing at the clinic pharmacy |